
	December 31, 2025				December 31, 2024
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization

Finite-lived intangible assets
Patents	$	4,806	$	(4,806)	$	4,806	$	(4,806)
Land use rights	727		(147)		637		(122)
Trademark	2,022		(1,736)		1,910		(1,685)
Technology	7,240		(4,777)		6,582		(3,933)
Customer relationships	19,528		(12,717)		17,399		(11,132)
	$	34,323	$	(24,183)	$	31,334	$	(21,678)
Indefinite-lived intangible assets
Goodwill	$	30,684			$	26,685

The aggregate amortization expense for other intangibles with finite lives, ranging from 1 year to 65 years, for the years ended December 31, 2025, 2024 and 2023 was $1.4 million, $1.8 million, and $1.8 million, respectively. Amortization expense is estimated to be $1.5 million for 2026, 2027, and 2028, $1.3 million for 2029, and $1.0 million for 2030. The weighted-average remaining amortization period is approximately 10.9 years. The weighted-average remaining amortization period by intangible asset class; land use rights, 64.7 years; trademark, 10.9 years; technology, 5.2 years and customer relationships, 8.5 years.

The Company may use both quantitative and qualitative approaches when testing goodwill for impairment. For selected reporting units where the qualitative approach is utilized, a qualitative evaluation of events and circumstances impacting the reporting unit is performed to determine if it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. If that determination is made, no further evaluation is necessary. Otherwise, the Company performs a quantitative impairment test on the reporting unit.

For the quantitative approach, the Company uses a combination of the income approach, which uses a discounted cash flow methodology, and the market approach, which uses comparable market multiples in computing fair value by reporting unit. The Company then compares the fair value of the reporting unit with its carrying value to assess if goodwill has been impaired. The fair value estimates are subjective and sensitive to significant assumptions, such as revenue growth rates, operating margins, the WACC, and estimated market multiples, which are affected by expectations of future market or economic conditions. The Company believes that the methodologies, significant assumptions, and weightings used are reasonable and result in appropriate fair values of the reporting units.

Impairment assessments inherently involve management judgments regarding a number of assumptions such as those described above. Due to the multiple variables inherent in arriving at the estimates of the reporting unit's fair value, differences in assumptions could have an effect on the estimated fair value of a reporting unit and could result in goodwill impairment charges in a future period.

As a result of actual performance for the EMEA reporting unit falling short of internal forecasts, combined with an increase in projected capital expenditures related to the construction of a new manufacturing facility in 2025 and 2026, management identified a potential indicator of impairment as of September 30, 2025. The Company performed an interim impairment assessment and based on this review, the estimated fair value of the EMEA reporting unit exceeded its carrying amount by approximately 30% and management concluded that no impairment of goodwill was required for the EMEA reporting unit as of September 30, 2025. The interim impairment assessment was performed using the same methodologies as the annual assessments discussed in Note 1 - Significant Accounting Policies and included revised forecasts, which are subject to various risks and uncertainties, including forecasted revenue, expenses and cash flows. As of December 31, 2025, the Company concluded there were no material changes in quantitative or qualitative considerations from the interim impairment assessment.

For all other reporting units, the Company performed the annual impairment test for Goodwill as of October 1. No other indicators of impairment were identified. There were no impairment charges recorded in 2025 or 2024.


	PLP-USA		The Americas		EMEA		Asia-Pacific		Total

Balance at January 1, 2024	$	3,078	$	10,582	$	15,837	$	—	$	29,497

Currency translation	—		(1,724)		(1,088)		—		(2,812)
Balance at December 31, 2024	3,078		8,858		14,749		—		26,685
Acquisitions	—		899		—		—		899

Currency translation	—		869		2,231		—		3,100
Balance at December 31, 2025	$	3,078	$	10,626	$	16,980	$	—	$	30,684